Ofatumumab subcutaneous injection for the treatment of relapsing forms of multiple sclerosis
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2022.2031982
Abstract: ABSTRACT Introduction In recent years, different studies have highlighted the importance of B cells in the pathophysiology of multiple sclerosis (MS): they secrete cytokines to modulate the inflammatory environment, present antigens for the activation of… read more here.
Keywords: subcutaneous injection; injection treatment; ofatumumab subcutaneous; treatment ... See more keywords